Azelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patients.
Zhao
Xiuli
X
Beijing Tongren Hospital, Capital Medical University, Beijing, China. Xiulizhao@medmail.com.cn
Wu
Feng
F
Jia
Sanqing
S
Qu
Peng
P
Li
Huimin
H
Zhao
Xingshan
X
Cao
Bo
B
Lin
Yiping
Y
Wang
Mulan
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D017311:Amlodipine / Q000008:administration & dosage* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001383:Azetidinecarboxylic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018660:Blood Pressure Monitoring, Ambulatory; D002681:China; D004095:Dihydropyridines / Q000008:administration & dosage* / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D004095:Dihydropyridines; D017311:Amlodipine; D001383:Azetidinecarboxylic Acid; C061679:azelnidipine